• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类固醇诱导的中心性浆液性脉络膜视网膜病变中的巩膜厚度

Scleral Thickness in Steroid-Induced Central Serous Chorioretinopathy.

作者信息

Sawaguchi Shota, Terao Nobuhiro, Imanaga Naoya, Wakugawa Sorako, Tamashiro Tamaki, Yamauchi Yukihide, Koizumi Hideki

机构信息

Department of Ophthalmology, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.

出版信息

Ophthalmol Sci. 2022 Feb 8;2(2):100124. doi: 10.1016/j.xops.2022.100124. eCollection 2022 Jun.

DOI:10.1016/j.xops.2022.100124
PMID:36249703
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9559089/
Abstract

PURPOSE

To evaluate and compare the scleral thickness of patients with idiopathic central serous chorioretinopathy (iCSC) and steroid-induced central serous chorioretinopathy (sCSC) using anterior-segment OCT.

DESIGN

Retrospective, comparative study.

PARTICIPANTS

One hundred ten eyes of 110 patients with central serous chorioretinopathy.

METHODS

We classified the patients into iCSC and sCSC groups and compared age, sex, spherical equivalent, axial length, subfoveal choroidal thickness (SCT), and scleral thickness. We measured scleral thickness 6 mm posterior to the scleral spur in 4 directions.

MAIN OUTCOME MEASURE

Scleral thickness in sCSC eyes.

RESULTS

We enrolled 96 and 14 eyes in the iCSC and sCSC groups, respectively. The sCSC group included a greater proportion of women than the iCSC group (42.9% and 13.5%, respectively;  = 0.020). We observed no between-group differences in age, spherical equivalent, axial length, or SCT. Univariate analysis revealed that the sCSC group had a significantly thinner sclera at the superior (423.4 μm vs. 346.6 μm; < 0.001), temporal (440.1 μm vs. 399.4 μm;  = 0.020), inferior (450.1 μm vs. 395.3 μm;  = 0.001), and nasal (436.6 μm vs. 391.9 μm;  = 0.002) points than the iCSC group. Multivariate analyses revealed that female sex (odds ratio, 4.322; 95% confidence interval, 1.025-18.224;  = 0.046) and mean scleral thickness (odds ratio, 0.972; 95% confidence interval, 0.955-0.990;  = 0.002) were significantly associated with sCSC.

CONCLUSIONS

The scleral thickness of eyes in the sCSC group was significantly thinner than that in the iCSC group. This suggests that the sclera has less involvement in the pathogenesis of sCSC than in that of iCSC.

摘要

目的

使用眼前节光学相干断层扫描(OCT)评估和比较特发性中心性浆液性脉络膜视网膜病变(iCSC)和类固醇性中心性浆液性脉络膜视网膜病变(sCSC)患者的巩膜厚度。

设计

回顾性比较研究。

研究对象

110例中心性浆液性脉络膜视网膜病变患者的110只眼。

方法

我们将患者分为iCSC组和sCSC组,比较年龄、性别、等效球镜度、眼轴长度、黄斑中心凹下脉络膜厚度(SCT)和巩膜厚度。我们在巩膜突后方6mm处的4个方向测量巩膜厚度。

主要观察指标

sCSC组眼的巩膜厚度。

结果

我们分别纳入iCSC组96只眼和sCSC组14只眼。sCSC组女性比例高于iCSC组(分别为42.9%和13.5%;P = 0.020)。我们观察到两组在年龄、等效球镜度、眼轴长度或SCT方面无差异。单因素分析显示,sCSC组在上(423.4μm对346.6μm;P < 0.001)、颞(440.1μm对399.4μm;P = 0.020)、下(450.1μm对395.3μm;P = 0.001)和鼻(436.6μm对391.9μm;P = 0.002)方位的巩膜明显比iCSC组薄。多因素分析显示,女性(比值比,4.322;95%置信区间,1.025 - 18.224;P = 0.046)和平均巩膜厚度(比值比,0.972;95%置信区间,0.955 - 0.990;P = 0.002)与sCSC显著相关。

结论

sCSC组眼的巩膜厚度明显薄于iCSC组。这表明巩膜在sCSC发病机制中的参与程度低于iCSC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/9559089/3272780c4323/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/9559089/cbe42c688d21/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/9559089/98ef1570aa37/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/9559089/61d0c92fdecf/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/9559089/3272780c4323/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/9559089/cbe42c688d21/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/9559089/98ef1570aa37/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/9559089/61d0c92fdecf/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dc5/9559089/3272780c4323/gr4.jpg

相似文献

1
Scleral Thickness in Steroid-Induced Central Serous Chorioretinopathy.类固醇诱导的中心性浆液性脉络膜视网膜病变中的巩膜厚度
Ophthalmol Sci. 2022 Feb 8;2(2):100124. doi: 10.1016/j.xops.2022.100124. eCollection 2022 Jun.
2
Scleral Thickness in Central Serous Chorioretinopathy.脉络膜视网膜病变中心性浆液性。
Ophthalmol Retina. 2021 Mar;5(3):285-291. doi: 10.1016/j.oret.2020.07.011. Epub 2020 Jul 16.
3
Short Axial Length Is Related to Asymmetric Vortex Veins in Central Serous Chorioretinopathy.短眼轴长度与中心性浆液性脉络膜视网膜病变中的不对称涡静脉相关。
Ophthalmol Sci. 2021 Oct 26;1(4):100071. doi: 10.1016/j.xops.2021.100071. eCollection 2021 Dec.
4
Clinical Factors Related to Loculation of Fluid in Central Serous Chorioretinopathy.与中心性浆液性脉络膜视网膜病变液体积聚相关的临床因素。
Am J Ophthalmol. 2022 Mar;235:197-203. doi: 10.1016/j.ajo.2021.09.009. Epub 2021 Sep 20.
5
SCLERAL THICKNESS IN THE FELLOW EYES OF PATIENTS WITH UNILATERAL CENTRAL SEROUS CHORIORETINOPATHY.单侧中心性浆液性脉络膜视网膜病变患者对侧眼巩膜厚度。
Retina. 2023 Sep 1;43(9):1573-1578. doi: 10.1097/IAE.0000000000003850.
6
Relationship Between Scleral Thickness and Choroidal Structure in Central Serous Chorioretinopathy.巩膜厚度与中心性浆液性脉络膜视网膜病变脉络膜结构的关系。
Invest Ophthalmol Vis Sci. 2023 Jan 3;64(1):16. doi: 10.1167/iovs.64.1.16.
7
CILIOCHOROIDAL EFFUSION IN CENTRAL SEROUS CHORIORETINOPATHY.脉络膜渗漏在中心性浆液性脉络膜视网膜病变中的表现。
Retina. 2022 Apr 1;42(4):730-737. doi: 10.1097/IAE.0000000000003376.
8
A pilot study of scleral thickness in central serous chorioretinopathy using anterior segment optical coherence tomography.前节光学相干断层扫描在中心性浆液性脉络膜视网膜病变巩膜厚度研究中的初步应用。
Sci Rep. 2021 Mar 12;11(1):5872. doi: 10.1038/s41598-021-85229-y.
9
Scleral Thickness in Simple Versus Complex Central Serous Chorioretinopathy.单纯型与复合型中心性浆液性脉络膜视网膜病变的巩膜厚度比较。
Am J Ophthalmol. 2024 May;261:103-111. doi: 10.1016/j.ajo.2024.01.025. Epub 2024 Jan 26.
10
Scleral Thickness as a Risk Factor for Central Serous Chorioretinopathy and Pachychoroid Neovasculopathy.巩膜厚度作为中心性浆液性脉络膜视网膜病变和厚脉络膜新生血管病变的危险因素
J Clin Med. 2023 Apr 24;12(9):3102. doi: 10.3390/jcm12093102.

引用本文的文献

1
[Stress and other risk factors in central serous chorioretinopathy-A myth?].[中心性浆液性脉络膜视网膜病变中的压力及其他风险因素——一种误解?]
Ophthalmologie. 2025 Mar;122(3):162-169. doi: 10.1007/s00347-024-02179-2. Epub 2025 Jan 17.
2
Influence of scleral thickness on photodynamic therapy outcomes in central serous chorioretinopathy.巩膜厚度对中心性浆液性脉络膜视网膜病变光动力疗法疗效的影响。
Acta Ophthalmol. 2025 May;103(3):e165-e175. doi: 10.1111/aos.16779. Epub 2024 Oct 20.
3
Central serous chorioretinopathy and the sclera: what we have learned so far.

本文引用的文献

1
Scleral Thickness in Central Serous Chorioretinopathy.脉络膜视网膜病变中心性浆液性。
Ophthalmol Retina. 2021 Mar;5(3):285-291. doi: 10.1016/j.oret.2020.07.011. Epub 2020 Jul 16.
2
Short axial length and hyperopic refractive error are risk factors of central serous chorioretinopathy.眼轴短和远视屈光不正都是中心性浆液性脉络膜视网膜病变的危险因素。
Br J Ophthalmol. 2020 Sep;104(9):1260-1265. doi: 10.1136/bjophthalmol-2019-315236. Epub 2019 Nov 28.
3
Dilatation of Asymmetric Vortex Vein in Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变中不对称涡静脉扩张
中心性浆液性脉络膜视网膜病变与巩膜:目前我们的认识。
Jpn J Ophthalmol. 2024 Sep;68(5):419-428. doi: 10.1007/s10384-024-01101-2. Epub 2024 Aug 16.
4
Pachychoroid disease: review and update.厚脉络膜疾病:综述与更新
Eye (Lond). 2025 Apr;39(5):819-834. doi: 10.1038/s41433-024-03253-4. Epub 2024 Aug 3.
5
Differential Expression of Sex-Steroid Receptors in the Choroid Aligns With Central Serous Chorioretinopathy Sex Prevalence Across Different Ages.脉络膜中性别类固醇受体的差异表达与不同年龄的中心性浆液性脉络膜视网膜病变的性别流行率一致。
Invest Ophthalmol Vis Sci. 2024 Jul 1;65(8):5. doi: 10.1167/iovs.65.8.5.
6
Genetic and Clinical Characteristics of Central Serous Chorioretinopathy With Steroid Use.使用类固醇的中心性浆液性脉络膜视网膜病变的遗传和临床特征
Cureus. 2024 Apr 20;16(4):e58631. doi: 10.7759/cureus.58631. eCollection 2024 Apr.
7
Central serous chorioretinopathy associated with nonspecific orbital inflammation: a case report.中心性浆液性脉络膜视网膜病变合并非特异性眼眶炎症:一例报告
J Int Med Res. 2024 Mar;52(3):3000605241233963. doi: 10.1177/03000605241233963.
8
Scleral changes in systemic lupus erythematosus patients using swept source optical coherence tomography.应用扫频源光学相干断层扫描仪观察系统性红斑狼疮患者巩膜改变。
Front Immunol. 2023 Nov 2;14:1278893. doi: 10.3389/fimmu.2023.1278893. eCollection 2023.
9
Evaluation of scleral thickness in patients with Fuchs endothelial dystrophy.富克斯内皮营养不良患者巩膜厚度的评估。
Graefes Arch Clin Exp Ophthalmol. 2023 Oct;261(10):2883-2889. doi: 10.1007/s00417-023-06107-z. Epub 2023 May 13.
10
Scleral Thickness as a Risk Factor for Central Serous Chorioretinopathy and Pachychoroid Neovasculopathy.巩膜厚度作为中心性浆液性脉络膜视网膜病变和厚脉络膜新生血管病变的危险因素
J Clin Med. 2023 Apr 24;12(9):3102. doi: 10.3390/jcm12093102.
Ophthalmol Retina. 2018 Feb;2(2):152-161. doi: 10.1016/j.oret.2017.05.013. Epub 2017 Aug 16.
4
Central serous chorioretinopathy with and without steroids: A multicenter survey.伴有和不伴有类固醇的中心性浆液性脉络膜视网膜病变:一项多中心调查。
PLoS One. 2019 Feb 28;14(2):e0213110. doi: 10.1371/journal.pone.0213110. eCollection 2019.
5
Pachychoroid disease.脉络膜增厚性疾病。
Eye (Lond). 2019 Jan;33(1):14-33. doi: 10.1038/s41433-018-0158-4. Epub 2018 Jul 11.
6
Central serous chorioretinopathy and glucocorticoids: an update on evidence for association.中心性浆液性脉络膜视网膜病变与糖皮质激素:关联证据的最新进展
Surv Ophthalmol. 2018 Jan-Feb;63(1):1-8. doi: 10.1016/j.survophthal.2017.06.008. Epub 2017 Jun 30.
7
CHOROIDAL THICKNESS OF CENTRAL SEROUS CHORIORETINOPATHY SECONDARY TO CORTICOSTEROID USE.使用皮质类固醇继发的中心性浆液性脉络膜视网膜病变的脉络膜厚度
Retina. 2017 Aug;37(8):1562-1567. doi: 10.1097/IAE.0000000000001380.
8
Morphological features in anterior scleral inflammation using swept-source optical coherence tomography with multiple B-scan averaging.使用具有多次B扫描平均功能的扫频源光学相干断层扫描技术观察前巩膜炎症的形态学特征
Br J Ophthalmol. 2017 Apr;101(4):411-417. doi: 10.1136/bjophthalmol-2016-308561. Epub 2016 Jul 7.
9
CHOROIDAL THICKNESS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: Assessment of Haller and Sattler Layers.中心性浆液性脉络膜视网膜病变患者的脉络膜厚度:对哈勒层和萨特勒层的评估
Retina. 2016 Sep;36(9):1652-7. doi: 10.1097/IAE.0000000000000998.
10
RISK FACTORS FOR CENTRAL SEROUS CHORIORETINOPATHY: A Systematic Review and Meta-Analysis.中心性浆液性脉络膜视网膜病变的危险因素:一项系统评价与Meta分析
Retina. 2016 Jan;36(1):9-19. doi: 10.1097/IAE.0000000000000837.